[go: up one dir, main page]

BR9909478A - Novos tratamentos para vários distúrbios do sistema nervoso - Google Patents

Novos tratamentos para vários distúrbios do sistema nervoso

Info

Publication number
BR9909478A
BR9909478A BR9909478-9A BR9909478A BR9909478A BR 9909478 A BR9909478 A BR 9909478A BR 9909478 A BR9909478 A BR 9909478A BR 9909478 A BR9909478 A BR 9909478A
Authority
BR
Brazil
Prior art keywords
disorders
nervous system
new treatments
various nervous
system disorders
Prior art date
Application number
BR9909478-9A
Other languages
English (en)
Inventor
Fred Hassan
John Michael Mccall
Duncan Paul Taylor
Philip F Von Voigtlander
Erik Ho Fong Wong
Original Assignee
Upjohn Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Upjohn Co filed Critical Upjohn Co
Publication of BR9909478A publication Critical patent/BR9909478A/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/535—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/535—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
    • A61K31/5375—1,4-Oxazines, e.g. morpholine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/20—Hypnotics; Sedatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
    • A61P25/32—Alcohol-abuse
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
    • A61P25/34—Tobacco-abuse
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
    • A61P25/36—Opioid-abuse

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Addiction (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Psychiatry (AREA)
  • Epidemiology (AREA)
  • Psychology (AREA)
  • Anesthesiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Saccharide Compounds (AREA)

Abstract

<B>NOVOS TRATAMENTOS PARA VáRIOS DISTúRBIOS DO SISTEMA NERVOSO<D> Esta aplicação de patente descreve o tratamento de Distúrbios do Viciado, Distúrbios por uso de Substâncias Psicoativas, Distúrbios por Intoxicação. Distúrbios por Inalação, Vício do álcool, Vício da Nicotina e ou Tabaco; e Distúrbio Hiperativo com Déficit de Atenção (ADHD); compreendendo a administração de uma dose não tóxica, terapeuticamente eficaz de Reboxetine e derivados e ou sais farmaceuticamente aceitáveis deste a um paciente.
BR9909478-9A 1998-04-09 1999-04-02 Novos tratamentos para vários distúrbios do sistema nervoso BR9909478A (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US8123198P 1998-04-09 1998-04-09
PCT/US1999/004289 WO1999052531A1 (en) 1998-04-09 1999-04-02 New treatments for nervous disorders

Publications (1)

Publication Number Publication Date
BR9909478A true BR9909478A (pt) 2000-12-19

Family

ID=22162900

Family Applications (1)

Application Number Title Priority Date Filing Date
BR9909478-9A BR9909478A (pt) 1998-04-09 1999-04-02 Novos tratamentos para vários distúrbios do sistema nervoso

Country Status (24)

Country Link
US (1) US6352986B1 (pt)
EP (1) EP1069900B1 (pt)
JP (1) JP2002511414A (pt)
KR (1) KR20010034758A (pt)
CN (1) CN1301164A (pt)
AT (1) ATE301462T1 (pt)
AU (1) AU756373B2 (pt)
BR (1) BR9909478A (pt)
CA (2) CA2634698A1 (pt)
CZ (1) CZ297346B6 (pt)
DE (1) DE69926616T2 (pt)
DK (1) DK1069900T3 (pt)
EA (1) EA200001049A1 (pt)
ES (1) ES2244189T3 (pt)
HU (1) HUP0102436A3 (pt)
IL (1) IL138855A0 (pt)
NO (1) NO20005059L (pt)
NZ (1) NZ507398A (pt)
PL (1) PL193797B1 (pt)
PT (1) PT1069900E (pt)
SK (1) SK14492000A3 (pt)
TR (1) TR200002868T2 (pt)
WO (1) WO1999052531A1 (pt)
ZA (1) ZA200004454B (pt)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6586427B2 (en) * 1998-04-09 2003-07-01 Pharmacia & Upjohn Company Treatments for nervous disorders
EP1632235A3 (en) * 1999-07-01 2006-06-14 Pharmacia & Upjohn Company LLC Use of highly selective norepinephrine reuptake inhibitors for the treatment of mental disorders
WO2001001973A2 (en) 1999-07-01 2001-01-11 Pharmacia & Upjohn Company Highly selective norepinephrine reuptake inhibitors and methods of using the same
HUP0204551A2 (hu) * 2000-03-07 2003-06-28 Eli Lilly And Co. Eljárás a pikkelysömör kezelésére
SE521512C2 (sv) 2001-06-25 2003-11-11 Niconovum Ab Anordning för administrering av en substans till främre delen av en individs munhåla
US20040102440A1 (en) * 2002-07-01 2004-05-27 Wong Erik Ho Fong Method of promoting smoking cessation
ES2968706T3 (es) 2002-12-20 2024-05-13 Niconovum Ab Una combinación de nicotina y celulosa
UA95454C2 (uk) 2005-07-15 2011-08-10 Амр Текнолоджи, Інк. Арил- і гетероарилзаміщені тетрагідробензазепіни і їх застосування для блокування зворотного захоплення норепінефрину, допаміну і серотоніну
JP5694645B2 (ja) 2006-03-16 2015-04-01 ニコノヴァム エービーＮｉｃｏｎｏｖｕｍ Ａｂ 改善された嗅ぎたばこ組成物
US20100069389A1 (en) * 2008-09-06 2010-03-18 Bionevia Pharmaceuticals, Inc. Novel forms of reboxetine
KR20120023072A (ko) 2009-05-12 2012-03-12 브리스톨-마이어스 스큅 컴퍼니 （Ｓ）-7-（〔1,2,4〕트리아졸〔1,5-ａ〕피리딘-6-일）-4-（3,4-디클로로페닐）-1,2,3,4-테트라하이드로이소퀴놀린의 결정형 및 이의 용도
MX2011011907A (es) 2009-05-12 2012-01-20 Albany Molecular Res Inc 7-([1,2,4,]triazolo[1,5-a]piridin-6-il)-4-(3,4-diclorofenil)-1,2, 3,4-tetrahidroisoquinolina y uso de la misma.
WO2012024397A2 (en) 2010-08-17 2012-02-23 Albany Molecular Research, Inc. 2,5-methano-and 2,5-ethano-tetrahydrobenzazepine derivatives and use thereof to block reuptake of norepinephrine, dopamine, and serotonin

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL56369A (en) 1978-01-20 1984-05-31 Erba Farmitalia Alpha-phenoxybenzyl propanolamine derivatives,their preparation and pharmaceutical compositions comprising them
EP0072177B1 (en) * 1981-08-07 1987-01-07 Holset Engineering Company Limited Impeller for centrifugal compressor
GB8419683D0 (en) 1984-08-02 1984-09-05 Erba Farmitalia 3-substituted derivatives of 1-amino-2-hydroxy-propane
US5281624A (en) * 1991-09-27 1994-01-25 Eli Lilly And Company N-alkyl-3-phenyl-3-(2-substituted phenoxy) propylamines and pharmaceutical use thereof
ZA958725B (en) * 1994-10-20 1997-04-16 Lilly Co Eli Treatment of disorders with duloxetine
US5658590A (en) * 1995-01-11 1997-08-19 Eli Lilly And Company Treatment of attention-deficit/hyperactivity disorder
WO1997003665A1 (en) * 1995-07-24 1997-02-06 Eli Lilly And Company Treatment of attention-deficit/hyperactivity disorder
UA56257C2 (uk) 1997-09-23 2003-05-15 Елі Ліллі Енд Компані Спосіб лікування неадекватної визивної поведінки
AU9214498A (en) * 1997-09-23 1999-04-12 Eli Lilly And Company Treatment of attention-deficit/hyperactivity disorder

Also Published As

Publication number Publication date
DE69926616D1 (de) 2005-09-15
KR20010034758A (ko) 2001-04-25
AU756373B2 (en) 2003-01-09
US6352986B1 (en) 2002-03-05
TR200002868T2 (tr) 2001-01-22
NZ507398A (en) 2004-01-30
PL193797B1 (pl) 2007-03-30
HUP0102436A3 (en) 2002-01-28
SK14492000A3 (sk) 2001-06-11
EP1069900B1 (en) 2005-08-10
PL346293A1 (en) 2002-01-28
CA2321157A1 (en) 1999-10-21
CN1301164A (zh) 2001-06-27
CZ20003671A3 (en) 2001-06-13
EP1069900A1 (en) 2001-01-24
ZA200004454B (en) 2002-04-24
CA2634698A1 (en) 1999-10-21
HUP0102436A2 (hu) 2001-11-28
WO1999052531A1 (en) 1999-10-21
PT1069900E (pt) 2005-10-31
IL138855A0 (en) 2001-10-31
NO20005059D0 (no) 2000-10-06
AU3449499A (en) 1999-11-01
ATE301462T1 (de) 2005-08-15
EA200001049A1 (ru) 2001-04-23
DE69926616T2 (de) 2006-05-24
ES2244189T3 (es) 2005-12-01
DK1069900T3 (da) 2005-10-31
NO20005059L (no) 2000-10-06
CZ297346B6 (cs) 2006-11-15
JP2002511414A (ja) 2002-04-16

Similar Documents

Publication Publication Date Title
BR0107983A (pt) Uso de pramipexol para o tratamento de enfermidades decorrentes de vìcios
BR9909478A (pt) Novos tratamentos para vários distúrbios do sistema nervoso
ES2164040T1 (es) Uso de agonistas del sitio de union de la glicina o de inhibidores de la absorcion de la glicina para el tratamiento de trastornos neuropsiquiatricos.
TW329387B (en) Pharmaceutical composition for treating airway passage and lung diseases comprising mometasone furoate
BR0205722A (pt) Formulação de liberação prolongada e método para o tratamento de um paciente que sofre de dor
DE60138547D1 (de) Topisch anwendbare arzneipräparate und verfahren zur behandlung
BR0011343A (pt) Dispositivo de distribuição de medicamento,e,métodos de administrar um medicamento por inalação,e de,tratamento de um paciente com distúrbio respiratório
BR9908510A (pt) Uso de um composto, composto, processo para a preparação de um composto, composição farmacêutica, e, processo de tratar um paciente que sofre de, ou em risco de, uma doença micobacteriana
BR0210075A (pt) Composto, composição farmacêutica, uso de um composto, e, métodos de tratamento ou profilaxia de doenças ou condições humanas, de distúrbios psicóticos ou distúrbios da debilitação intelectual e de fadiga de vÈo, cessamento de fumar, dependência de nicotina, dores, e para a colite ulcerativa
BR9802537A (pt) Método para anestesiar um paciente humano antes de cirurgias de porte dose unitária e sistema farmacêutico para administração
ES2153906T3 (es) Uso de incienso para el tratamiento de la enfermedad de alzheimer.
NO994165L (no) Anvendelse av deskarboetoksyloratadin for fremstilling av et medikament for behandling av urininkontinens, reisesyke og svimmelhet
PE134999A1 (es) Uso de aminometil-cromanos sustituidos para el impedimento de la degeneracion neuronal y para el estimulo de la regeneracion neuronal
IT1313585B1 (it) Uso di agonisti dei recettori gabab per la terapia di mantenimentodell&#39;astinenza da nicotina in soggetti nicotino-dipendenti.
DE69200711D1 (de) Pharmazeutische Zusammensetzungen enthaltend Fluticasonpropionat und Oxikonazol oder dessen Salz zur lokalen Anwendung.
BR0313411A (pt) Uso de reboxetina para o tratamento de ondas de calor
BR9916432A (pt) Compostos de triazinona para o tratamento de doenças devido ao sarcosystis, neospora e ao toxoplasma
BR0010006A (pt) Utilização do saredutante e de seus sais farmaceuticamente aceitáveis para o preparo de medicamentos úteis no tratamento ou na prevenção do conjunto das perturbações do humor, das perturbações da adaptação ou das perturbações mistas ansiedade-depressão
BR0207866A (pt) Uso de flumazenil na preparação de um medicamento para o tratamento da dependência de cocaìna
EE04330B1 (et) Levosimendani transmukoossed koostised ja nende kasutamine ravimi valmistamiseks
BR0112131A (pt) Composições farmacêuticas e métodos para uso
BRPI0415651A (pt) métodos para tratar, prevenir, modificar e/ou administrar fibromialgia, e para reduzir ou evitar um efeito adverso associado com a administração de um segundo ingrediente ativo em um paciente sofrendo de fibromialgia, e, composição farmacêutica
BR9909476A (pt) Novos tratamentos para distúrbios nervosos
BR0208488A (pt) Agonistas de kapa-opiato para o tratamento de doenças da bexiga
BR0112939A (pt) Compostos para o tratamento de distúrbios de dependência

Legal Events

Date Code Title Description
B07A Application suspended after technical examination (opinion) [chapter 7.1 patent gazette]
B15K Others concerning applications: alteration of classification

Free format text: ALTERADA DE INT.CL: A61K 31/5375, A61P 25/00, A61P 25/30, A61P 25/32, A61P 25/34, A61P 25/36

Ipc: A61K 31/5375 (2007.10), A61P 25/00 (2007.10), A61P

B09B Patent application refused [chapter 9.2 patent gazette]

Free format text: INDEFERIMENTO DO PRESENTE PEDIDO, UMA VEZ QUE A MATERIA CONTIDA NO MESMO NAO E PETENTEAVEL ( ART 10 INCISO VIII DA LPI )

B09B Patent application refused [chapter 9.2 patent gazette]

Free format text: MANTIDO O INDEFERIMENTO UMA VEZ QUE NAO FOI APRESENTADO RECURSO DENTRO DO PRAZO LEGAL.